Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2995 (LINC02995) is a human gene that encodes a long non-coding RNA (lncRNA) molecule and does not encode a protein.[1][3][5][7][10] It is located on chromosome 5 (5q35.2) and is categorized as an lncRNA, which broadly participate in the regulation of gene expression at transcriptional, post-transcriptional, and epigenetic levels, but for LINC02995 specifically no detailed or disease-associated biological roles have been well characterized in the available literature.[1][3][5][7][10] Essential context and supporting details: - Long intergenic non-protein coding RNA 2995 (LINC02995) is *not* a protein-coding gene, nor is it a receptor, enzyme, transporter, or other classical therapeutic target category.[1][3][5][7][10] - It has been cataloged in genomic resources such as HGNC (HGNC:27744), Ensembl (ENSG00000253955), and GeneCards, confirming its long non-coding RNA identity and genomic coordinates.[1][3][5][7][10] - Alternate names in genetic databases include CTB-33O18.3.[10] - There is no published evidence linking LINC02995 to specific biological processes, therapeutic roles, drug interactions, disease associations, or biomarker utility at this time; it is therefore *not considered a therapeutic target* and is not associated with receptor/enzyme/transcription factor classifications. - Its classification as an lncRNA places it into the "Other" molecular class for structured data. - No safety, biomarker, or pharmacological concerns or utility are documented for this lncRNA gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2995 (LINC02995).